Top 200 Cell and Gene Facility Index and Biomanufacturers Subscription Database

The ONLY Global Cell and Gene facilities database subscription that actively tracks over 200+ dedicated Cell and Gene Therapy facilities providing cell therapy and gene therapy development and manufacturing services for biopharmaceuticals.

Based on 30 years of evaluating and benchmarking the biopharmaceutical and life sciences industry, this database is updated continually and includes comprehensive information and insights.

Top 200 Cell and Gene Facility Index ranks each ‘dedicated’ cell and gene therapy facility and provides regional quantitative analysis of biomanufacturing regions and clusters:

• Total bioreactor liter capacity
• Cell and Gene Therapy service expertise
• Future Biomanufacturing capacity coming online
• Number of commercial and clinical biological products manufactured
• Revenue estimates
• Strengths and Challenges
• Technologies and expertise, and much more

• Identify ideal partners: develop key networks with CT/GT partners
• Identify specialized expertise: cell or gene therapy, pDNA, mRNA
• Early-stage companies: sponsors can identify potential manufacturing partners
• Facility siting: Locate qualified employees; reduce hiring challenges
• Sales territory allocations: Determine where and how to staff territories
• Market Competition: Identify competitors’ strengths and weaknesses
• Real estate valuation: For facilities, based on regional attractiveness
• HR and Recruiters: Looking for a critical mass of educated and skilled staff
• Industry Growth: Find where the industry is growing most rapidly
• Emerging Regions: CT/GT Facilities in China, India, Latin America, Middle East regions
• Facility Ranking: How do CT/GT facilities rank, in skills, employment, capacity